Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,202
Closed -$566K 206
2024
Q1
$566K Sell
5,202
-110
-2% -$12.7K 0.1% 106
2023
Q4
$629K Buy
+5,312
New +$591K 0.12% 96
2021
Q3
Sell
-4,656
Closed -$543K 143
2021
Q2
$543K Buy
4,656
+193
+4% +$21.5K 0.13% 84
2021
Q1
$455K Buy
4,463
+51
+1% +$5.27K 0.11% 92
2020
Q4
$463K Buy
4,412
+88
+2% +$9.21K 0.13% 87
2020
Q3
$478K Buy
4,324
+1,172
+37% +$130K 0.16% 69
2020
Q2
$338K Sell
3,152
-462
-13% -$46.4K 0.13% 79
2020
Q1
$331K Sell
3,614
-44
-1% -$4.08K 0.18% 79
2019
Q4
$316K Buy
+3,658
New +$320K 0.13% 92

Other funds holding AKAM

CFO4Life Group's AKAM Position: Q2 2024 in Review

CFO4Life Group sold out of Akamai (AKAM) in Q2 2024, closing a stake of 5,202 shares — an estimated $566K sold.

CFO4Life Group first reported a position in AKAM in Q4 2019 and held it in 9 quarters. The position peaked at $629K in Q4 2023. 666 funds tracked by Wall St. Rank hold AKAM as of Q2 2024.

  • CFO4Life Group reported no remaining Akamai position as of Q2 2024 after selling out during the quarter.
  • CFO4Life Group sold 5,202 Akamai shares in Q2 2024, an estimated $566K.
  • CFO4Life Group first reported a position in Akamai in Q4 2019 and held it in 9 quarters.
  • CFO4Life Group's Akamai position peaked at $629K in Q4 2023.
  • 666 funds tracked by Wall St. Rank held Akamai as of Q2 2024.

Based on CFO4Life Group's 13F filing for Q2 2024, filed 31 Jul 2024.